𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of vinpocetine on the sleep-wake cycle of rats

✍ Scribed by Adam Sarkadi; Judit Laszy; Lászlö Szporny

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
370 KB
Volume
14
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biochemical modulation of the sleep–wake
Biochemical modulation of the sleep–wake cycle: Endogenous sleep-inducing factors
✍ Oscar Arias-Carrión; Salvador Huitrón-Reséndiz; Gloria Arankowsky-Sandoval; Eric 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

## Abstract Regulation of the sleep–wake cycle involves diverse brain circuits and molecules. Further complexity has been introduced by the recognition of sleep‐promoting factors that accumulate in the brain naturally or during prolonged waking. The variety of sleep‐inducing molecules includes pept

Assessment of hypnotic effects in the ra
Assessment of hypnotic effects in the rat: Influence of the sleep-awake cycle
✍ Dr. Leonard T. Meltzer; Kevin A. Serpa 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB 👁 1 views

The influence of the sleep-awake cycle of the rat on the apparent hypnotic effects of two benzodiazepine hypnotics, triazolam (short half-life) and flurazepam (long half-life), was assessed. Cortical electroencephalographic recordings from freely moving animals were used to determine whether the rat

Single cell activity patterns of peduncu
Single cell activity patterns of pedunculopontine tegmentum neurons across the sleep-wake cycle in the freely moving rats
✍ Subimal Datta; Donald F. Siwek 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB

Microinjections of the excitatory amino acid, L-glutamate into the cholinergic cell compartment of the pedunculopontine tegmentum (PPT) of the rat induces both wakefulness and/or rapid eye movement (REM) sleep depending on the glutamate dosage. However, no studies have systematically recorded the el

Impact of the novel antidepressant agome
Impact of the novel antidepressant agomelatine on disturbed sleep–wake cycles in depressed patients
✍ Maria-Antonia Quera-Salva; Patrick Lemoine; Christian Guilleminault 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 1 views

## Abstract ## Background Disturbance of sleep–wake cycles is common in major depressive disorder (MDD), usually as insomnia, but also as hypersomnia or reduced daytime alertness. Agomelatine, an MT~1~ and MT~2~ receptor agonist and 5‐HT~2C~ receptor antagonist, represents a novel approach in MDD,